Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults.

Nicholson AN, Turner C, Stone BM, Robson PJ.

J Clin Psychopharmacol. 2004 Jun;24(3):305-13.

PMID:
15118485
2.

Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers.

Martin-Santos R, Crippa JA, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, Allen P, Seal M, Langohr K, Farré M, Zuardi AW, McGuire PK.

Curr Pharm Des. 2012;18(32):4966-79. Review.

PMID:
22716148
3.

Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.

Russo EB, Guy GW, Robson PJ.

Chem Biodivers. 2007 Aug;4(8):1729-43. Review.

PMID:
17712817
4.
5.

The combined effect of marihuana and dextroamphetamine.

Forney R, Martz R, Lemberger L, Rodda B.

Ann N Y Acad Sci. 1976;281:162-70. Review.

PMID:
798521
6.

Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition.

Colizzi M, Bhattacharyya S.

Curr Addict Rep. 2017;4(2):62-74. doi: 10.1007/s40429-017-0142-2. Epub 2017 Apr 29. Review.

8.

Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.

Szaflarski JP, Bebin EM.

Epilepsy Behav. 2014 Dec;41:277-82. doi: 10.1016/j.yebeh.2014.08.135. Epub 2014 Oct 1. Review.

PMID:
25282526
9.

[Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids].

Oreja-Guevara C.

Rev Neurol. 2012 Oct 1;55(7):421-30. Review. Spanish.

10.

THC:CBD spray and MS spasticity symptoms: data from latest studies.

Rekand T.

Eur Neurol. 2014;71 Suppl 1:4-9. doi: 10.1159/000357742. Epub 2014 Jan 22. Review.

PMID:
24457846
11.

Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.

Fowler CJ.

Clin Pharmacol Ther. 2015 Jun;97(6):587-96. doi: 10.1002/cpt.84. Epub 2015 May 2. Review.

PMID:
25669486
12.

Cannabidiol in medical marijuana: Research vistas and potential opportunities.

Rong C, Lee Y, Carmona NE, Cha DS, Ragguett RM, Rosenblat JD, Mansur RB, Ho RC, McIntyre RS.

Pharmacol Res. 2017 Jul;121:213-218. doi: 10.1016/j.phrs.2017.05.005. Epub 2017 May 10. Review.

PMID:
28501518
13.

The relationship between cannabidiol and psychosis: A review.

Silva TB, Balbino CQ, Weiber AF.

Ann Clin Psychiatry. 2015 May;27(2):134-41. Review.

PMID:
25954940
14.

Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.

Fasinu PS, Phillips S, ElSohly MA, Walker LA.

Pharmacotherapy. 2016 Jul;36(7):781-96. doi: 10.1002/phar.1780. Review.

PMID:
27285147
15.

Cannabis, Cannabinoids, and Sleep: a Review of the Literature.

Babson KA, Sottile J, Morabito D.

Curr Psychiatry Rep. 2017 Apr;19(4):23. doi: 10.1007/s11920-017-0775-9. Review.

PMID:
28349316
16.

Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.

Burstein S.

Bioorg Med Chem. 2015 Apr 1;23(7):1377-85. doi: 10.1016/j.bmc.2015.01.059. Epub 2015 Feb 7. Review.

PMID:
25703248
17.

Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.

Anderson GD, Chan LN.

Clin Pharmacokinet. 2016 Nov;55(11):1353-1368. Review.

PMID:
27106177
18.

In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease.

Watt G, Karl T.

Front Pharmacol. 2017 Feb 3;8:20. doi: 10.3389/fphar.2017.00020. eCollection 2017. Review.

19.

Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.

Zettl UK, Rommer P, Hipp P, Patejdl R.

Ther Adv Neurol Disord. 2016 Jan;9(1):9-30. doi: 10.1177/1756285615612659. Review.

20.

The effect of cannabis use on memory function: an update.

Schoeler T, Bhattacharyya S.

Subst Abuse Rehabil. 2013 Jan 23;4:11-27. doi: 10.2147/SAR.S25869. eCollection 2013. Review.

Supplemental Content

Support Center